Strict LDL Monitoring Helps Reduce Plaque Volume

colesterol ldl placasThe aim of this study was to explore the relationship between temporal changes in coronary plaque volume and the intensity of lipid lowering treatments using coronary computed tomography (CTA).

 

Coronary computed tomography has acceptable accuracy in terms of quantitative measurement on plaque volume, enough to identify changes in volume according to LDL levels.

 

This multicenter study included 467 patients undergoing multislice CT angiography over more than two years (mean 3.2 years), whose lab data were available within one month of both baseline and follow-up coronary CTA. Out of these patients, 147 were enrolled in the study, for they had visible plaque compromising 336 vessels.

 

Researchers compared patients reaching a cutoff value of 70 mg/dl LDL vs. those who did not. Patients below 70 mg/dl showed a significant reduction of plaque progression vs. those above 70 mg/dl (12.7 ± 38.2 mm3 vs. 44.2 ± 73.6 mm3, respectively; p=0.014).

 

In multivariable analyzis, the only factor influencing plaque progression was LDL cholesterol level.

 

Conclusion

Strict control of LDL levels significantly reduces plaque volume progression accordion to the non-invasive measurement with multislice CTA.

 

Original Title: Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression A Serial CT Angiography Study.

Reference: Sanghoon Shin et al. J Am Coll Cardiol Img. 2016. Online First.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...